1-153810202-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP2BP4
The NM_020699.4(GATAD2B):c.1757C>T(p.Ser586Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,964 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Synonymous variant affecting the same amino acid position (i.e. S586S) has been classified as Likely benign.
Frequency
Consequence
NM_020699.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GATAD2B | NM_020699.4 | c.1757C>T | p.Ser586Leu | missense_variant | 11/11 | ENST00000368655.5 | |
GATAD2B | XM_047426115.1 | c.1760C>T | p.Ser587Leu | missense_variant | 11/11 | ||
GATAD2B | XM_047426117.1 | c.1757C>T | p.Ser586Leu | missense_variant | 11/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GATAD2B | ENST00000368655.5 | c.1757C>T | p.Ser586Leu | missense_variant | 11/11 | 1 | NM_020699.4 | P1 | |
GATAD2B | ENST00000634544.1 | c.1757C>T | p.Ser586Leu | missense_variant | 11/11 | 5 | P1 | ||
GATAD2B | ENST00000634408.1 | c.1709C>T | p.Ser570Leu | missense_variant | 11/11 | 5 | |||
GATAD2B | ENST00000637918.1 | c.135+1529C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459964Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726272
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 25, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GATAD2B protein function. This variant has not been reported in the literature in individuals affected with GATAD2B-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 586 of the GATAD2B protein (p.Ser586Leu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.